Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.

McKesson Corp.’s McKesson Anesthesia Care clinical decision support system was the subject of a class I recall, a rarity in the health information technology sector that could offer insights into FDA oversight of the space going forward.

Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.